Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akerley

Showing results (31-40 of 227) with videos related to

Pageof 23
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Oncologists' current opinion on the treatment of colon carcinomaMartin Majer, Wallace Akerley, Scott K Kuwada
Frontiers in Cellular and Infection Microbiology|August 25, 2012
Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesisSandy M S Wong, Brian J Akerley
Clinical Lung Cancer|March 19, 2023
Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to OsimertinibJarrod T Smith, Sonam Puri, Wallace Akerley
American Journal of Clinical Oncology|March 26, 2015
Squamous non-small cell lung cancer as a distinct clinical entityTrudy G Oliver, Jesal Patel, Wallace Akerley
Medicine and Health, Rhode Island|November 1, 1996
A woman with a balanced autosomal translocation who received chemotherapy while pregnantW Y Kim, T W Wehbe, W Akerley
Infection and Immunity|April 4, 2023
Copper Efflux System Required in Murine Lung Infection by Haemophilus influenzae Composed of a Canonical ATPase Gene and Tandem Chaperone Gene CopiesSandy M Wong, Jeffrey Gawronski, Brian J Akerley
Proteins|April 17, 2008
Structure of YraM, a protein essential for growth of Haemophilus influenzaeJ Vijayalakshmi, Brian J Akerley, Mark A Saper
Lung Cancer (Amsterdam, Netherlands)|March 11, 1998
Subcutaneous interleukin-2 as initial therapy for patients with extensive small cell lung cancer: a phase II trial of Cancer and Leukemia Group BG Clamon, J Herndon, W Akerley, et al.
Journal of Thoracic Disease|May 1, 2018
Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care?Anna W Chalmers, Shiven B Patel, Wallace Akerley
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2026
TTF-1-Negative Lung Adenocarcinoma: An Aggressive Subtype Refractory to Immunotherapy and KRAS<sup>G12C</sup> InhibitionHenry U Arnold, Wallace Akerley, Eric L Snyder
Pageof 23

Showing results (31-40 of 227) with videos related to

Sort By:
Pageof 23
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Oncologists' current opinion on the treatment of colon carcinomaMartin Majer, Wallace Akerley, Scott K Kuwada
Frontiers in Cellular and Infection Microbiology|August 25, 2012
Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesisSandy M S Wong, Brian J Akerley
Clinical Lung Cancer|March 19, 2023
Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to OsimertinibJarrod T Smith, Sonam Puri, Wallace Akerley
American Journal of Clinical Oncology|March 26, 2015
Squamous non-small cell lung cancer as a distinct clinical entityTrudy G Oliver, Jesal Patel, Wallace Akerley
Medicine and Health, Rhode Island|November 1, 1996
A woman with a balanced autosomal translocation who received chemotherapy while pregnantW Y Kim, T W Wehbe, W Akerley
Infection and Immunity|April 4, 2023
Copper Efflux System Required in Murine Lung Infection by Haemophilus influenzae Composed of a Canonical ATPase Gene and Tandem Chaperone Gene CopiesSandy M Wong, Jeffrey Gawronski, Brian J Akerley
Proteins|April 17, 2008
Structure of YraM, a protein essential for growth of Haemophilus influenzaeJ Vijayalakshmi, Brian J Akerley, Mark A Saper
Lung Cancer (Amsterdam, Netherlands)|March 11, 1998
Subcutaneous interleukin-2 as initial therapy for patients with extensive small cell lung cancer: a phase II trial of Cancer and Leukemia Group BG Clamon, J Herndon, W Akerley, et al.
Journal of Thoracic Disease|May 1, 2018
Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care?Anna W Chalmers, Shiven B Patel, Wallace Akerley
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2026
TTF-1-Negative Lung Adenocarcinoma: An Aggressive Subtype Refractory to Immunotherapy and KRAS<sup>G12C</sup> InhibitionHenry U Arnold, Wallace Akerley, Eric L Snyder
Pageof 23